Comment on Ipp and Kumar. A Clinical Conundrum: Intensifying Glucose Control in the Presence of Advanced Diabetic Retinopathy. Diabetes Care 2021;44:2192 –2193

We were interested by the recent article from Ipp and Kumar (1), who questioned whether we should slow down glycemic normalization in subjects with type 2 diabetes and advanced retinopathy due to the recent report from the Veterans Affairs Diabetes Trial (VADT) (2). Diabetic retinopathy is a strong predictor of other complications, such as cardiovascular events (3) and lower extremity arterial disease (4), and we wondered whether a quick decline of HbA1c relates to their occurrence.
Source: Diabetes Care - Category: Endocrinology Source Type: research